Diagnosing and Treating Low Blood Sugar Levels
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study ID
- NCT00001276
- Status
- Recruiting
Conditions
- Hypoglycemia
- Insulinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Study Details
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.
Key Dates
- Start date
- May 21, 1991
- Status verified
- May 2026
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Patients with hypoglycemiaPatients with hypoglycemia due to diverse etiologies.
Primary Outcome Measure
Treatment Outcomes [ Time Frame: every 1-3 months ]
Central Contacts
- Craig S Cochran, R.N.(301) 402-1880
- Ranganath Muniyappa, M.D.(301) 451-7702
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | - |
Find similar trials in Bethesda, MD
By research site
Related Studies
- Differing Levels of HypoglycemiaEARLY_PHASE1 · Recruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass SurgeryEARLY_PHASE1 · Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- Fluorodopa F 18 in Congenital Hyperinsulinism and InsulinomaPHASE1 · Recruiting · Cook Children's Health Care System · Fort Worth, Texas
- Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic CounterregulationRecruiting · Pennington Biomedical Research Center · Baton Rouge, Louisiana